Figure 1From: Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis Decision tree for the imminent preterm birth models. The decision tree used to compare standard care (no treatment) with administration of magnesium sulphate to patients in whom preterm birth at < 32+0 weeks gestation is imminent.Back to article page